Fuente: Prohibición Partners Lugar: General Report Contents
Jump to any section in the series
















Introduction →
Definitions And Scope →
Executive Summary →
Key Trends →

Market Value →
Legislation and Regulation →
Consumer Attitudes →
Healthcare Providers’ Attitudes →

Spotlight On Health →
Psychedelics – Timeline of Key Developments →
Countries to Watch →
Psychedelic Profiles →

Key Psychedelics Deep Dive →
Other Psychedelics of Note →
Psychedelics as Medicine: Potential Therapies →
Psychedelics and Technology →

Psychedelics Per Country →
Psychedelics and The Law →
Patents and Intellectual Property →
Therapy Practitioners →

Psychedelic Research →
Glossary →


No matches. Try a different keyword.












Definitions of key acronyms and terms used throughout The Psychedelics as Medicine Report.




ABCD
EFGI
KLMN
OPRS
TUVW



Search glossary

Clear




A


ACT
acceptance and commitment therapy


ADHD
attention deficit hyperactivity disorder


AUD
alcohol use disorder



B


BTD
Breakthrough Therapy designation



C


CBCT
Cognitive behavioural cognitive therapy


CBT
Cognitive behavioural therapy


CIIS
California Institute of Integral Studies


CSE
Canadian Stock Exchange


CNS
central nervous system



D


DALYs
disability adjusted life years


DEA
Drug Enforcement Administration


DMT
Dimethyltryptamine


DSCP
Drug software combination products



E


ECT
electroconvulsive therapy


EDs
eating disorders


EEG
electroencephalogram


EMA
European Medicine Agency



F


FDA
Food and Drug Administration


fMRI
functional magnetic resonance imaging



G


GITA
Global ibogaine therapy alliance


GMP
Good Manufacturing Practice



I


ICL
Imperial College London


IND
investigational new drug


IM
intramuscular


IP
intellectual property


IPO
initial public offering


IV
intravenous



L


LSD
lysergic acid diethylamide



M


MAOIs
monoamine oxidase inhibitors


MAPS
Multidisciplinary Association for Psychedelic Studies


MAPS PBC
Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation


MDD
major depressive disorder


MDMA
methylenedioxymethamphetamine


MMA
Mind Medicine Australia



N


NGO
non-government organisation


NHS
National Health Service



O


OCD
obsessive-compulsive disorder


OUD
opioid use disorder



P


PAT
psychedelic assisted therapy


PPD
postpartum depression


PTSD
post-traumatic stress disorder



R


RCT
randomised controlled trial



S


SI
suicidal ideation


SNRIs
serotonin and norepinephrine reuptake inhibitors


SSRIs
selective serotonin reuptake inhibitors


SUD
substance use disorder



T


TBI
traumatic brain injury


TGA
Therapeutic Goods Administration


TRD
treatment-resistant depression



U


UCLA
University of California, Los Angeles



V


VR
virtual reality



W


WHO
World Health Organisation




















← Previous



Download report ↓



Back To Start →




Prefer the full dataset? Download the complete report (PDF).








Download the full report
Enter your details to access the PDF instantly.

×










The post Glossary – PSYCH: The Psychedelics As Medicine Report 3rd Edition appeared first on Prohibition Partners.